Biotech Values

[biomaven0]

>>ALXN acquires GEVA for $226/sh* in cash and stock

However much the bears scream about biotech being a bubble, as long as the sector gets support from buyouts like this, it will continue strong.

We still haven't seen any moves by GILD - their billions must be burning a hole in their very deep pockets.

Maybe we should have a contest to see who GILD will buy (it's going to be more than one company I suspect).

Peter